WASHINGTON (DC News Now) — September is Prostate Cancer Awareness Month, and according to the National Cancer Institute (NCI), approximately one in eight men will be diagnosed with prostate cancer in ...

Landmark trials have driven a shift from radical mastectomies to less invasive, breast-conserving surgeries. Non-invasive breast carcinomas, when detected early, have highly favorable survival and ...

Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide. It is primarily caused by the human papillomavirus (HPV), a viral infection that spreads ...

When it comes to men's health, prostate cancer tends to fly under the radar. The disease can go undetected for years, especially in the early stages when symptoms may not be noticeable. Prostate ...

Learn more about the newly approved wearable treatment that disrupts pancreatic cancer tumor growth while letting patients continue daily life at home.

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously ...

Zusduri demonstrated a 72.2% 24-month response durability in LG-IR-NMIBC patients, leading to FDA approval as a non-surgical treatment option. The ENVISION trial enrolled 240 patients, focusing on ...

Inlexzo is approved for BCG-unresponsive NMIBC with CIS, offering a new treatment option for patients with limited alternatives. The SunRISe-1 trial showed an 82% complete response rate, with 51% ...

Bladder cancer frequently announces itself through symptoms that patients dismiss as minor urinary issues, and that delay ...

Gwyneth Paltrow's fans are accusing her of making 'dangerous' claims that could discourage cancer patients from lifesaving ...

Beccy holds a PhD in Biological Science, a Master’s in Molecular Biology of Parasites and Disease Vectors, and a Bachelor’s in Human Biology and Forensic Science. Beccy holds a PhD in Biological ...